-
Bahnemann H G, 1990: Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine[J]. Vaccine, 8, 299-303. doi: 10.1016/0264-410X(90)90083-X
-
Caron L, Flores E F, Weiblen R, Scherer C F, Irigoyen L F, Roehe P M, Odeon A, Sur J H, 2002: Latent infection by bovine herpesvirus type-5 in experimentally infected rabbits: virus reactivation, shedding and recrudescence of neurological disease[J]. Vet Microbiol, 84, 285-295. doi: 10.1016/S0378-1135(01)00441-2
-
Chung H, Kim T W, Kwon M, Kwon I C, Jeong S Y, 2001: Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system[J]. J Control Release, 71, 339-350. doi: 10.1016/S0168-3659(00)00363-1
-
Davison A J, Eberle R, Ehlers B, Hayward G S, McGeoch D J, Minson A C, Pellett P E, Roizman B, Studdert M J, Thiry E, 2009: The order Herpesvirales[J]. Arch Virol, 154, 171-177. doi: 10.1007/s00705-008-0278-4
-
DesCoteaux L, Cecyre D, Elsener J, Beauchamp G, 2003: Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1[J]. Can Vet J, 44, 816-821.
-
Duque H, Marshall R L, Israel B A, Letchworth G J, 1989: Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits[J]. Vaccine, 7, 513-520. doi: 10.1016/0264-410X(89)90275-2
-
Engels M, Steck F, Wyler R, 1981: Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction endonuclease analysis[J]. Arch Virol, 67, 169-174. doi: 10.1007/BF01318601
-
Hierholzer J C and Killington R A. 1996. Virus isolation and quantitation, p. 25-46. In Mahy B W J and Kangro H O (ed.), Virology methods manual. Academic Press, London.
-
Ioannou X P, Griebel P, Hecker R, Babiuk L A, van Drunen Littel-van den Hurk S, 2002: The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides[J]. J Virol, 76, 9002-9010. doi: 10.1128/JVI.76.18.9002-9010.2002
-
Kamaraj G, Rana S K, Srinivasan V A, 2009: Serological response in cattle immunized with inactivated oil and Algel adjuvant vaccines against infectious bovine rhinotracheitis[J]. New Microbiol, 32, 135-141.
-
Lesko J, Veber P, Hrda M, Feketeova M, 1993: Large-scale production of infectious bovine rhinotracheitis virus in cell culture on microcarriers[J]. Acta Virol, 37, 73-78.
-
Miller J M, Whetstone C A, Bello L J, Lawrence W C, 1991: Determination of ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus-1 to cause abortion in cattle[J]. Am J Vet Res, 52, 1038-1043.
-
Muylkens B, Meurens F, Schynts F, Farnir F, Pourchet A, Bardiau M, Gogev S, Thiry J, Cuisenaire A, Vanderplasschen A, Thiry E, 2006: Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle[J]. J Gen Virol, 87, 2149-2154. doi: 10.1099/vir.0.81969-0
-
OIE. 2004. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th ed. OIE, Paris, France.
-
Parreno V, Lopez M V, Rodriguez D, Vena M M, Izuel M, Filippi J, Romera A, Faverin C, Bellinzoni R, Fernandez F, Marangunich L, 2010: Development and statistical validation of a guinea pig model for vaccine potency testing against Infectious Bovine Rhinothracheitis (IBR) virus[J]. Vaccine, 28, 2539-2549. doi: 10.1016/j.vaccine.2010.01.035
-
Pastoret P P, Thiry E, 1985: Diagnosis and prophylaxis of infectious bovine rhinotracheitis: the role of virus latency[J]. Comp Immunol Microbiol Infect Dis, 8, 35-42. doi: 10.1016/0147-9571(85)90052-9
-
Patel J R, 2004: Evaluation of a quadrivalent inactivated vaccine for the protection of cattle against diseases due to common viral infections[J]. J S Afr Vet Assoc, 75, 137-146.
-
Patel J R, 2005: Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines[J]. Vaccine, 23, 4054-4061. doi: 10.1016/j.vaccine.2004.12.010
-
Peters A R, Thevasagayam S J, Wiseman A, Salt J S, 2004: Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves[J]. Prev Vet Med, 66, 63-77. doi: 10.1016/j.prevetmed.2004.08.001
-
Rossi C R, Kiesel G K, 1982: Effect of infectious bovine rhinotracheitis virus immunization on viral shedding in challenge-exposed calves treated with dexamethasone[J]. Am J Vet Res, 43, 1576-1579.
-
Ruiz-Saenz J, Jaime J, Vera V, 2009: Bovine Herpesvirus-1 Vaccine's: A Look From The Past To The Immunization Future[J]. Acta biol Colomb, 14, 3-20.
-
Ruiz-Saenz J, Jaime J, Ramirez G, Vera V, 2012: Molecular and in vitro characterization of field isolates of bovine herpesvirus-1[J]. Virol Sin, 27, 26-37. doi: 10.1007/s12250-012-3221-5
-
Schudel A A, Carrillo B J, Wyler R, Metzler A E, 1986: Infections of calves with antigenic variants of bovine herpesvirus 1 (BHV-1) and neurological disease[J]. Zentralbl Veterinarmed B, 33, 303-310.
-
Toussaint J F, Letellier C, Paquet D, Dispas M, Kerkhofs P, 2005: Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1[J]. Vaccine, 23, 5073-5081. doi: 10.1016/j.vaccine.2005.06.006
-
Valera A R, Pidone C L, Massone A R, Quiroga M A, Riganti J G, Corva S G, Galosi C M, 2008: A simple method of infecting rabbits with Bovine herpesvirus 1 and 5[J]. J Virol Methods, 150, 77-79. doi: 10.1016/j.jviromet.2008.03.008
-
Zimmerman A D, Buterbaugh R E, Herbert J M, Hass J M, Frank N E, Luempert Iii L G, Chase C C, 2007: Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers[J]. J Am Vet Med Assoc, 231, 1386-1389. doi: 10.2460/javma.231.9.1386